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Purpose: Our aim was to identify long-term predictive factors of the morphology-based
outcome (MBO) of bare platinum coiled intracranial aneurysms.
Materials and Methods: A retrospective analysis of 96 bare platinum coiled intracranial aneur-
ysms followed up from 1997 to 2016 using pre- and post-contrast 3D time-of-ﬂight MR
angiography (MRA) was performed. Logistic regression analysis was used to identify factors
associated with a positive history of surrounding coil mass enhancement (SCME) and poor
MBO. Spearman's rank correlation test was used to analyze the relationship between the
initial angiographic result (IAR) class, sequential change of the SCME category, and MBO grade.
Results: Factors independently associated with poor MBO were incomplete IAR (OR = 14.94,
95%CI: 2.46, 289.21, P = 0.002) and a history of SCME (OR = 4.13, 95% CI: 1.05, 18.65, P = 0.043). The
MBO grade strongly correlated with the IAR class (correlation coefﬁcient [r] = 0.84, P < 0.0001).
MBO grade correlated with sequential change of the SCME category (r = 0.56, P < 0.0001). The
sequential change of the SCME category correlated with IAR class (r = 0.53, P < 0.0001).
Conclusion: Although IAR and its class were strong long-term predictive factors of MBO, a
history of SCME and upgrading of sequential change of SCME category were also long-term
predictive factors of the MBO of bare platinum coiled intracranial aneurysms.
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Endovascular embolization with electrically detachable coils is
accepted as a primary treatment for intracranial aneurysms.
However occlusion of the large aneurysm sac cannot always be
achieved, and even if the aneurysm is occluded completely,
delayed recanalization, early rerupture, and symptomatic
mass effect due to growth of the coiled aneurysm may occur
[1–5].
Digital subtraction angiography (DSA) is the standard
procedure for the visualization of the hemodynamic and
morphological changes of coiled intracranial aneurysms.
However DSA is invasive and has some risk of neurological
complications [6]. Magnetic resonance angiography (MRA) has
been performed as the next best standard alternative for
assessing the degree of occlusion and morphology of coiled
intracranial aneurysms. Various MRA methods i.e. 3 dimen-
sional (3D) time-of-ﬂight (TOF) MRA, dynamic contrast-
enhanced MRA, those performed on a 3 T machine, and a
combination of these have been reported [7–9]. Some authors
prefer to use contrast medium in the evaluation of large or
giant aneurysms [10].
Enlargement of the aneurysmal diameter following coil
compaction with or without intraluminal thrombus formation
[11,12], and extrusion of coils [5] have been considered to
indicate a high risk for rerupture of coiled aneurysms and the
need for re-intervention. In addition, several recent reports
have noted coiled aneurysm wall enhancement or perianeur-
ysmal enhancement and discussed their etiology and relation
to the clinical outcome of coiled aneurysms [13–19].
This prompted us to assess the long-term predictive factors
for the morphology based outcome (MBO) of bare platinum
coiled intracranial aneurysms using both pre-and post-
contrast 3D TOF MRA in this study.
2. Materials and methods
This study was performed in a single center with the approval
of the institutional ethics committee, and after informed
consent was obtained from all subjects.
In our hospital, all intracranial saccular aneurysms are
potential candidates for coiling, and from May 1997 to
November 2016, 266 intracranial aneurysms in 246 consecutive
patients were treated with various platinum coils.
In this study, we deﬁned the ‘‘long-term follow-up’’ as
‘‘more than 12 months’’ after coiling therapy based on the
deﬁnition of Raymond [20]. Duration of the follow-up period
was counted from the date of each coiling procedure. Inclusion
criteria were patients with coiled aneurysms followed for more
than 12 months who underwent both pre- and post-contrast
enhanced 3D TOF MRA at 1 week, 1 month, and 6 and
12 months after the coiling therapy. Ninety-six bare platinum
coiled intracranial aneurysms were entered into this study.
2.1. Exclusion criteria
Aneurysms treated by stent assisted coiling and those
associated with another ipsilateral aneurysm treated with asurgical clips were excluded because surgical clips induced a
strong metal artifact that interferes with the evaluation.
Aneurysms treated with biologically active coils were excluded
because those coils overemphasize the contrast effect. Forty-
nine aneurysms were excluded because of the absence of pre-
or post-contrast enhanced TOF examination, and 44 because
of patient refusal of contrast medium use. Twenty-four
aneurysms were excluded because the follow-up duration
was shorter than 12 months, and 10 because the follow-up
examination was performed at another hospital with only pre-
contrast 3D TOF MRA. Twenty-one aneurysms present in the
cavernous sinus, 5 in contact with a vein or dura mater, 5
treated by stent assisted coiling, 10 associated with another
ipsilateral aneurysm treated with a surgical clip, and 2 treated
with biologically active coils were also excluded.
2.2. Diagnostic DSA
Angiographic procedures were performed on a monoplane C-
arm angiographic system. All aneurysmal sizes were always
measured prospectively. Before 3D rotational angiography
became available (before 2000) in our hospital, we measured
aneurysmal size, neck width and maximum height by using
the method of a simultaneously positioned metal scale or
material of known size (such as a coin) at the same distance
from the X-ray tube and X-ray detector as the target aneurysm
during the image acquisition of DSA.
Maximum diameter was deﬁned as the largest diameter of
all cross-sections along the height of the aneurysm, and neck
width was deﬁned as the diameter of the neck cross-section
plane perpendicular to the maximum height [21].
2.3. Endovascular procedure
Most patients were coiled under general anesthesia by one of
three neurosurgeons (N.U., M.M., and K.M.). Systemic antic-
oagulation with anticoagulant (a bolus of 5000 IU of heparin,
followed by continuous infusion of 1000 IU/h) was used from
the beginning of treatment in unruptured aneurysms. In
ruptured aneurysms, which were treated in the majority of
cases within 24–48 h after subarachnoid hemorrhage (SAH),
heparin was ﬁrst given after at least partial occlusion of the
aneurysm was achieved. Coils were inserted into the aneu-
rysmal sac until no more could be delivered.
Angiographic ﬁndings were recorded immediately after
coiling. In cases in which the X-ray photograph did not show
any change, routine follow-up DSA was performed at 6 and
12 months and annually thereafter. We deﬁned the ﬁndings of
DSA performed immediately after coiling as the initial
angiographic results (IAR). We decided upon any imaging or
symptomatic deterioration to retreat all aneurysms showing
an increase in the size of the remnant sac or dilatation of the
residual neck including bleb formation with or without
maximum diameter dilatation.
2.4. MR angiography
Pre-and post-contrast 3D TOF MRA was used for the evaluation
of coiled intracranial aneurysms. Three dimensional MIP
images, source images, and multiplanar reconstructed (MPR)
Table 1 – Morphology based Outcome Grade.
Grade Description
1 Completely coiled
2 Remnant sac or residual neck
(stable)
3 Remnant sac dilatation
4 Residual neck growth
5 Maximum diameter dilatation
6 Rupture
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assessment. Slice thickness of source images and MPR images
was 0.5 mm after 2008, and 1.0 mm before 2008. All the MR
examinations were performed using a 1.5 T or 3 T MR unit
(both were Signa; GE Medical Systems, Milwaukee, WI). Three
tesla MR was available from 2008. An 8-channel phased-array
head coil or bird cage coil was used at 1.5 T, and an 8-channel
phased-array head coil was used at 3 T with the following
scanning parameters: TR/TE 25/3 ms; ﬂip angle 208on 1.5 T,
24/3.4; 208 on 3 T. Post contrast enhanced 3D TOF MRA was
performed after intravenous injection of 0.1 ml/kg gadolinium
contrast medium. Follow-up MRA was performed annually
from 12 months after coiling.
2.5. Methods of analysis
Because hemodynamic evaluation of coiled aneurysms is
difﬁcult by non-invasive imaging, we employed MBO in this
analysis. MBO is deﬁned not only by follow-up MRA or DSA at
ﬁxed intervals but also by the X ray or clinical result, with the
latter two determined by the assessment of the neurosurgeon
in charge of the examination at that time. We graded MBO as
shown in Table 1, and schematically shown in Fig. 1. The MBO
were divided into good or poor (good: grade 1, 2 versus [vs.]
poor: grade 3, 4, 5, 6) depending on the necessity for
retreatment.
Signs of MBO grade progression have been clariﬁed to
include remnant sac dilatation by coil compaction, residual
neck growth or extrusion of coils, and maximum diameter
dilatation of coiled aneurysms as the major risk factors forFig. 1 – Schematic representation of the grade 1–5 of
morphology based outcome. Black area shows coil mass.rupture or rerupture of coiled aneurysms [5,22–26]. On the
other hand, a stable angiographic result during a 12-month is
predictive of a low risk of morphological deterioration [25].
We deﬁned the surrounding coil mass enhancement
(SCME) as the contrast enhancement effect appearing around
the hypointense coil mass not only aneurysmal wall but also
contrast ﬁlling between the coil mass and aneurysmal intima
determined by simultaneous evaluation of both pre- and post-
contrast 3D TOF MRA source images and MPR images.
Evaluation of the SCME between past and present MRA was
performed comparing images obtained from the same static
magnetic ﬁeld MRI. According to previously reported follow-up
results about sequential change of aneurysmal wall or
perianeurysmal or peripheral/circumferential coil mass en-
hancement, sequential change of the SCME can be roughly
grouped as negative, positive but likely to disappear in future,
and progressive [15,16,18]. We modiﬁed and applied categori-
zation of the sequential change of the SCME shown in Table 2.
We analyzed the association between the SCME and
predictive variables including total duration of follow-up,
age, sex, location, multiplicity, ruptured or unruptured,
maximum diameter, neck width, and IAR, and then between
those predictive variables plus SCME and the MBO.
The IAR was determined based on the degree of aneurysm
occlusion according to the Raymond classiﬁcation: class 1:
complete occlusion, class 2: residual neck, and class 3:
remnant sac [20,27]. Although sequential change of the SCME
in growing aneurysms is difﬁcult to evaluate because of
stretching of the aneurysmal wall we deﬁned the increase of
the SCME as the appearance of contrast effect at a previously
unenhanced portion or increase of contrast effect or thicken-
ing at any portion of previous enhancement.
Pre-and post-contrast MR angiography evaluations were
performed retrospectively by two of four neuroradiologists with
over 10 years' experience who were blinded to the patients'
clinical information and previously acquired images. After
independent review, when any discrepancies were noted, the
evaluation was repeated with a third neuroradiologist addedTable 2 – Categorization of sequential change of the
surrounding coil mass enhancement.
Category Description
0 Continue to be negative
1 Disappear
2 Decrease
3 Stable
4 Appear
5 Increase
Table 3 – Univariate and multivariate analysis of the relationship of evaluation factors to surrounding coil mass enhancement.
Univariate analysis Multivariate analysis
Surrounding coil mass enhancement
Evaluation factors Negative*
n = 64 (100)
Positivey
n = 32 (100)
P value OR 95% CI P value OR 95% CI P value
Total duration
of follow-up
Average  SD month 62.9  38.2 79.0  50.8 0.230
Median, 25%IQR, 75%IQR 51, 34, 80 77, 33.8, 114 0.086 1 month increments 1.01 1.00–1.02 0.087 1 1.00–1.02 0.070
Age Average  SD year 60.8  8.9 60.6  10.1 0.960 >60 vs. 260 1.29 0.55–3.03 0.563
Median, 25%IQR, 75%IQR 61, 54, 69 60.5, 53, 71 0.907 1 year increments 1.00 0.95–1.05 0.906
Sex Male 25 (39) 13 (41)
Female 39 (61) 19 (59) Female vs. Male 1.07 0.44–2.53 0.883
Location Anterior circulation 53 (83) 22 (69)
Posterior circulation 11 (17) 10 (31) Posterior vs. Anterior 2.2 0.81–5.95 0.123
Multiplicity Solitary 47 (73) 24 (75)
Multiple 17 (27) 8 (25) Multiple vs. Solitary 1.1 0.42–2.99 0.869
Ruptured or
Unruptured
Unruptured 39 (61) 17 (53)
Ruptured 25 (39) 15 (47) Ruptured vs. Unruptured 1.4 0.58–3.26 0.465
Maximum
diameter
210 mm 43 (67) 7 (22)
>10 mm 21 (33) 25 (78) >10 mm vs. 210 mm 7.3 2.84–20.90 <0.0001
Average  SD mm 8.4  3.2 11.6  3.2 <0.0001
Median, 25%IQR, 75%IQR 8, 7, 10 12, 10, 13 <0.0001 1 mm increments 1.4 1.18–1.67 <0.0001 1.2 1.03–1.52 0.020
Neck width 24 mm 41 (64) 8 (25)
>4 mm 23 (36) 24 (75) >4 mm vs. 24 mm 5.35 2.23–14.53 0.0002
Average  SD. mm 3.4  1.4 4.7  1.9 0.0007
Median, 25%IQR, 75%IQR 3, 2, 4 4, 3.3, 6 0.0003 1 mm increments 1.6 1.23–2.20 0.0004 1.2 0.88–1.73 0.222
Initial
angiographic
result
Complete 46 (72) 9 (28)
Incomplete 18 (28) 23 (72) Incomplete vs. Complete 6.5 2.61–17.52 <0.0001 3 0.99–9.00 0.052
Note: Data in parentheses are percentages. IQR, interquartile range; OR, odds ratio; CI, conﬁdence interval.
* Negative means category 0.
y Positive means category 1–5.
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Table 4 – Univariate and multivariate analysis of the relationship of evaluation factors to morphology based outcome.
Univariate analysis Multivariate analysis
Morphology based outcome
Evaluation factors Good:
n = 78 (100)
Poor:
n = 18 (100)
P value OR 95% CI P value OR 95% CI P value
Total duration
of follow-up
Average  SD. month 66.0  40.2 78.0  54.8 0.679
Median, 25%IQR, 75%IQR 57.5, 36, 86.3 72.5, 26.8, 125.3 0.290 1 month increments 1.01 0.99–1.02 0.294
Age Average  SD. year 60.4  9.2 62.3  9.3 0.478 >60 vs. 260 1.42 0.50–4.21 0.510
Median, 25%IQR, 75%IQR 61, 53.8, 68.3 63, 52, 72 0.439 1 year increments 1.02 0.97–1.09 0.430
Sex Male 31 (40) 7 (39)
Female 47 (60) 11 (61) Female vs. Male 1.04 0.37–3.09 0.947
Location Anterior circulation 63 (81) 12 (67)
Posterior circulation 15 (19) 6 (33) Posterior vs. Anterior 2.10 0.64–6.39 0.209
Multiplicity Solitary 59 (76) 12 (67)
Multiple 19 (24) 6 (33) Multiple vs. Solitary 1.55 0.49–4.60 0.443
Ruptured or
Unruptured
Unruptured 47 (60) 9 (50)
Ruptured 31 (40) 9 (50) Ruptured vs. Unruptured 1.52 0.54–4.30 0.429
Maximum
diameter
210 mm 47 (60) 3 (17)
>10 mm 31 (40) 15 (83) >10 mm vs. 210 mm 7.58 2.27–34.70 0.0006
Average  SD.mm 8.7  3.2 12.6  3.3 <0.0001
Median, 25%IQR, 75%IQR 8.5, 7, 11 12, 11, 13.3 <0.0001 1 mm increments 1.41 1.18–1.77 <0.0001 1.22 0.96–1.59 0.107
Neck width 24 mm 47 (60) 2 (11)
>4 mm 31 (40) 16 (89) >4 mm vs. 24 mm 12.1 3.16–80.16 <0.0001
Average  SD.mm 3.5  1.6 5.1  1.7 0.0004
Median, 25%IQR, 75%IQR 3, 2, 5 4.5, 4, 6 0.0004 1 mm increments 1.65 1.22–2.32 0.0009 1.16 0.73–1.84 0.528
Initial
angiographic
result
Complete 54 (69) 1 (6)
Incomplete 24 (31) 17 (94) Incomplete vs. Complete 38.25 7.22–708.78 <0.0001 14.94 2.46–289.21 0.002
Surrounding
coil mass
enhancement
Negative 60 (77) 4 (22)
Positive 18 (23) 14 (78) Positive vs. Negative 11.7 3.68–40.34 <0.0001 4.13 1.05–18.65 0.043
Note: Morphology based outcome: good means Grade 1 or 2, poor means Grade 3, 4, 5, or 6 in Table 1.
Data in parentheses are percentages. IQR, interquartile range; OR, odds ratio; CI, conﬁdence interval.
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Fig. 2 – (a) Axial source image of three dimensional (3D)
post-contrast time-of-flight (TOF) MR angiography (MRA) in
56-year-old-man with 12.2 mm maximum diameter
unruptured basilar tip aneurysm obtained at 74 months
after coiling shows no definite surrounding coil mass
enhancement (SCME). In this case, coiling was performed
once and the initial angiographic result was class 2. (b)
Axial source image of post-contrast 3D TOF MRA obtained
135 months from coiling shows aneurysm maximum
diameter dilatation with intraluminal thrombus (small
arrow) and appearance of SCME (arrows). Sequential
change of the SCME category was 4 and morphology based
outcome grade was defined as 5.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 1 1 6 – 1 2 6 121until a consensus was reached. Then we picked out recoiled
cases and demonstrated their clinical details.
2.6. Statistics
We used the JMP statistical software program (S.A.S. Institute
Inc., Version 10.0.1) for data analysis. Although the numeric
value of recoiled aneurysms changed during the long follow-
up period, we counted even multi-recoiled aneurysms as a
single aneurysm and used the data at the ﬁrst coiling for the
statistical analysis. All P values less than 0.05 were considered
statistically signiﬁcant. Univariate and multivariate logistic
regression analyses were performed to determine the statisti-
cal signiﬁcance between a positive history of SCME and poor
MBO between the following factors: total duration of follow-
up, age, sex, location, multiplicity, manifestation of occur-
rence, maximum diameter, neck width, IAR, with SCME added
in the case of MBO evaluation. The multivariate model
included the predictors with a probability value of 0.1 or less
on univariate analysis. For the multivariate logistic regression
analysis, aneurysmal size and neck width were classiﬁed into
the nearest whole number in mm and this 1 mm increment
measurement values were used for the statistics. The results
are presented as odds ratio (OR) as estimates of relative risk
with the 95% conﬁdence intervals (CI).
We used the Spearman's rank correlation test to calculate
the correlation coefﬁcients (r) between IAR class, MBO grade
and sequential change of the SCME category.
3. Results
3.1. Demographics and initial angiographic results
Patient age ranged from 33 to 78 years (mean, 60.8, median, 61
years, interquartile range (IQR) = 16 years and 58 (60%)
aneurysms were in women and 38 (40%) in men. The mean
interval of total follow-up was 68.5 months. Finally our results
were all deﬁned by the MRA results. Twenty cases had multiple
aneurysms, 5 sets of which were independently counted as 2
aneurysms in our study because they both satisﬁed our
inclusion criteria, while 71 cases had solitary aneurysms.
Posterior circulation aneurysms were 21 (22%), and 75 (78%)
were located in the anterior circulation. Forty (42%) and 56
(58%) aneurysms presented with and without SAH respective-
ly. Maximum diameter ranged from 3.0 mm to 22.3 mm
(average  SD, 9.5  3.5, median, 9.3). Neck width ranged from
2.1 mm to 9.2 mm (average  SD, 3.8  1.7, median, 3.2). There
was no statistical difference in the total duration of follow-up
between negative vs. positive history of the SCME group and
good vs. poor MBO group (Tables 3 and 4).
3.1.1. Univariate and multivariate logistic regression analysis
Univariate and multivariate analysis of the relation of follow-
up duration, demographics, clinical, imaging, and measure-
ment factors with a positive or negative history of the SCME
and poor or good MBO were shown in Tables 3 and 4. On the
multivariate analysis, maximum diameter in 1 mm incre-
ments was the only predictor statistically signiﬁcantly
independently associated with SCME. Both incomplete IARand a history of SCME were independent predictors that were
statistically signiﬁcant for poor MBO.
3.1.2. Sequential change of SCME, Morphology based outcome
and Recoiled cases
Sixty-four (67%) aneurysms showed category 0 sequential
change of SCME, 14 (15%) category 1, 4 (4%) category 2, 2 (2%)
category 3, 4 (4%) category 4 (Fig. 2), and 8 (8%) category 5
(Figs. 3 and 4). Fifty-three (55%) aneurysms were grade 1 MBO,
25 (26%) grade 2, 2 (2%) grade 3, 4 (4%) grade 4, 10 (10%) grade 5,
and 2 (2%) grade 6.
Intraluminal thrombosed aneurysms that were categorized
as 4, 5 or 6 on sequential change of SCME resulted in maximum
diameter dilatation and resulted in MBO grade 5 or 6 being
found in 7 aneurysms.
Fig. 3 – (a) Axial source image of post-contrast three
dimensional (3D) time-of-flight (TOF) MR angiography (MRA)
obtained at 6 months after fourth coiling in a 72-year-old-
woman (case 1 in Table 5) with ruptured left internal carotid-
posterior communicating aneurysm shows the surrounding
coil mass enhancement (SCME) (arrow). This aneurysm's
maximum diameter was 10.2 mm at onset. At the fourth
coiling, this aneurysm grew to 13.4 mm. In this case, the
initial angiographic result after the fourth coiling was class
3. (b) Post-contrast 3D TOF MRA source images obtained
18 months after the fourth coiling show increase of the
SCME and maximum diameter dilatation (arrow). Remnant
sac dilatation was evident (small arrow). Five months after
this MR study, she died of rupture of this aneurysm.
Sequential change of the SCME categorized 5 and
morphology based outcome grade was judged as grade 6.
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the incomplete IAR cases that could be followed-up at least 12
months showing sequential change of SCME category 0, 1, 2, 3,
and 5 that resulted in MBO grade 1 to 6. There was even one
case whose sequential change of SCME category 0 resulted in
grade 4 MBO.
3.1.3. Correlation coefﬁcient analysis
The MBO grade and IAR the had a statistically strong
correlation (r = 0.84, P < 0.0001). Sequential change of theSCME category and initial angiographic result classiﬁcation
had a moderate correlation (r = 0.53, P < 0.0001). The SCME
category and the MBO grade were moderately correlated
(r = 0.56, P < 0.0001).
4. Discussion
Being able to identify the long-term predictive factors
associated with an unfavorable outcome or morphological
recurrence of coiled intracranial aneurysms has been a major
task in neuroradiology. At present, factors identiﬁed as
signiﬁcant predictors of coiled aneurysm recurrence include
IAR, increasing follow-up time, posterior circulation, and
larger aneurysm [22–26]. Our results showed that the IAR
and positive history of SCME were independent predictors of
MBO. Moreover, appearance or increase of the SCME correlated
with worsening of the MBO.
Bare platinum coiled aneurysmal wall enhancement which
is a representative feature of the SCME, had been considered to
reﬂect a normal healing response, although Fanning et al.
found that incompletely occluded and recurrent aneurysms
more frequently show wall enhancement than completely
occluded ones [17]. But in their study the follow-up duration
was mostly within 12 months. Moreover they included
biologically active coils in their study group, but because of
the extension of inﬂammation to arachnoid membrane or
brain parenchyma those emphasize the enhancement
[13,17,19]. Brain edema or hydrocephalus induced by coiled
aneurysms showing wall enhancement was also reported in
coiled aneurysms using bare platinum coils [15,18]. Wall
enhancement often appears in large or giant thrombosed
aneurysms. Neovascular formation induced by thrombus is
considered to be the mechanism underlying the growth of
large or giant aneurysms showing aneurysmal wall enhance-
ment [28]. In our study, SCME appeared not only in the
aneurysmal wall but also around the border between the coil
mass and intraluminal thrombus. This means that neovas-
cular formation at the surface of the coil mass may be the
source of thrombus or conversely intraluminal thrombus may
form neovessels on the contact surface of the coil mass.
The probability of aneurysm rupture is related not only to
its morphology but also its hemodynamic character. Rupture
of untreated saccular intracranial aneurysm occurs most
frequently at the aneurysm fundus, the second most fre-
quently at the lateral wall, and the least frequently at the
aneurysm neck [29]. Rerupture points immediately after
coiling have been reported to be both the neck and dome
[30]. Maximum diameter dilatation is thought to be a risk factor
for rerupture [2–4]. Residual neck dilatation with extrusion of
coils resulting in rupture has also been described [5]. The bleb
of an aneurysm is its thin bulging portion whose wall is fragile
and easily ruptured. Hemodynamic study reveals that the ﬂow
velocity in a bleb is low while its nature is turbulent. Large or
giant aneurysms also reveal low intraluminal velocity and
turbulent property and are often accompanied by an intra-
luminal thrombus [11]. Intraluminal slow and turbulent ﬂow
has a saturation effect on 3D TOF MRA, making it difﬁcult to
differentiate intraluminal thrombus from such heterogeneous
ﬂow.
Fig. 4 – (a) Post-contrast three dimensional (3D) time-of-flight (TOF) MR angiography (MRA) sagittal reconstructed 0.5 mm slice
image of a 62-year-old-man (case 9 in Table 5) with ruptured basilar tip aneurysm obtained at 42 months from second coiling
shows the surrounding coil mass enhancement (SCME) (arrow). (b) Pre-and (c) post-contrast enhanced TOF MRA sagittal
reconstructed image obtained at 82 months from the second coiling shows enlargement of the SCME (arrows). Sequential
change of the SCME was category 5. Two months later, rerupture occurred and a third coiling was performed. Morphology
based outcome grade was judged to be 6. (d) Digital subtraction angiography immediately after recoiling shows that additional
coils were inserted into both anterior and posterior blebs (arrows), but the initial angiographic result was judged as class 3.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 1 1 6 – 1 2 6 123Nagahara et al. reported that wall enhancement was
frequently observed on ruptured aneurysms [31]. Su et al.
reported that aneurysmal wall enhancement is a common
phenomenon that in most cases remains stable over years [32].
We consider that the mechanism underlying the aneurysmal
wall enhancement of post-embolization intracranial aneu-
rysm may not be attributable to a single etiology, but rather to
a complicated overlap of multiple etiologies. Some of these
have already been reported [13,17,19]. So we employed SCME
as an evaluation maker.
SCME includes many pathological phenomena such as vasa
vasorum proliferation in the coiled aneurysm wall, granulation
or inﬂammation of perianeurysmal arachnoid membrane or
brain parenchyma, neovascular formation between intralum-
inal thrombus and coil mass, and recurrent or newly developed
vascular ﬂow such as bleb formation. Some incompletely coiled
aneurysms have revealed negative SCME during all follow-up
periods, suggesting that such aneurysms should be monitored
carefully using other imaging methods such as X-ray photog-
raphy and DSA. Such incomplete IAR aneurysms are subjected
to less mechanical or biological effects from the coil mass on
the aneurysm intima because the embolization achievement is
weak, or the character of the aneurysmal intima is less likely to
reveal any response to coils. Completely coiled aneurysms
often showed category 1 or 2, suggesting that some decrease of
the SCME might be the most desirable clinical course.
Small aneurysms that are completely occluded and remain
stable at 6 months follow-up or those showing a stableangiographic result after a 12-month interval may be at low
risk for morphological deterioration. Large unstable aneur-
ysms that need recoiling should be carefully followed. Coil
compacted aneurysms with an initially small diameter but
whose residual neck or remnant sac is small, stable, and
impossible to recoil are followed without retreatment. Large
aneurysms that reveal a slow ﬂow remnant sac with
maximum diameter dilatation or a bleb at the residual neck
showing isointensity to the coil mass may have a lumen that is
occasionally overlooked and not subjected to post-contrast 3D
TOF MRA [10]. Such aneurysms or ones with an intraluminal
thrombus require a change in the therapeutic strategy with
recoiling undertaken as soon as possible. Such aneurysms
show category 4 or 5 sequential change of the SCME.
5. Limitations
This study was conducted in only a single university, rather
than a multicenter study. The study design was a retrospective
review and can be said to have been a little after ﬁtted. Some
MR angiographic technical differences were present between
the cases of early follow-up cases and more recently coiled
cases. The introduction of rotational angiography machine
and appearance of 3 T MRI may also have affected our results.
Our deﬁnition of MBO has two standards being deﬁned by not
only the MRA ﬁndings but also the clinical feature of
aneurysmal rupture. The ﬁnal decision of MBO was decided
Table 5 – Case presentation of recoiled aneurysms.
Case Age.
years,
Sex
Location Ruptured or Unruptured
Reason for recoiling
Duration of previous
coiling to recoiling
(months)
Maximum
diameter (mm)
Neck width
(mm)
Initial
angiographic
result class
Sequential
change of
surrounding
coil mass
enhancement
category #
Morphology-based
outcome grade #
1 72, F PCoA Ruptured 0 10.2 5.1 2 STTM STTM
Coil compaction and regrowth 3 11.2 5.2 3 STTM STTM
Coil compaction and regrowth 9 12.8 5.3 3 STTM STTM
Coil compaction and regrowth 10 13.4 7.4 3 5 6
2 53, M ACoA Ruptured 0 13.5 8.9 3 STTM STTM
Coil compaction and regrowth 10 15.6 8.4 3 STTM STTM
Coil compaction and regrowth 7 20.2 8.1 3 5 5
3 54, F MCA Ruptured 0 8.0 5.3 3 STTM STTM
Coil compaction and regrowth 5 10.2 5.0 3 STTM STTM
Coil compaction and regrowth 6 12.0 5.1 3 5 5
4 60, F ACoA Unruptured 0 10.4 3.0 3 2 3
Coil compaction 13 10.1 3.2 3 2 3
Coil compaction 28 10.9 3.3 3 1 2
5 53, F BA tip Unruptured 0 12.0 4.7 3 STTM STTM
Coil compaction 7 12.4 4.2 2 3 3
6 50, F MCA Ruptured 0 13.4 3.8 2 0 4
Coil compaction 19 13.7 3.2 3 0 3
7 73, F BA tip Ruptured 0 16.3 5.5 2 5 STTM
Coil compaction and regrowth 24 18.8 5.5 2 5 5
8 60, M PICA Unruptured 0 12.2 4.3 3 STTM STTM
Coil compaction 11 12.0 4.1 3 1 3
9 62, F BA tip Ruptured 0 8.8 5.3 2 3 3
Coil compaction and regrowth 57 9.3 5.2 2 5 5
Rerupture 84 13.0 6.2 3 5 6
10 68, F PCoA Unruptured 0 20.2 5.2 2 3 3
Coil compaction 28 20.1 5.9 2 1 1
Note: # Surrounding coil mass enhancement and morphology-based outcome were categorized and judged at least 12 months after previous coiling.
STTM: shorter than twelves months; PCoA: posterior communicating artery; ACoA: anterior communicating artery; MCA: middle cerebral artery; BA: basilar artery; PICA: posterior inferior cerebellar
artery.
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charge of the patients at that time. Our results may also had
been potentially been inﬂuenced by this lack of uniformity.
Follow-up reading of sequential change of SCME required
much time for the interpretation of each case. Although
evaluation of pre-and post-contrast MR angiography was
performed in a blinded manner, this method lacks accuracy,
because some of the neuroradiologists who participated in this
study are in charge of daily MRA reading. Statistically, we
simply classiﬁed the SCME into only negative or positive
depending on the presence/appearance or not during the total
follow-up, but this bisection is rather rough and the based on
relatively little evidence. Finally even with the permission of
the ethics committee and patient's consent, the usage of
contrast medium itself should be reconsidered.
6. Conclusions
Incomplete IAR and a history of SCME are the long-term
predictive factors for poor MBO of bare platinum coiled
intracranial aneurysms. The MBO grade correlated with
sequential change of the SCME category
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